Formulation Development Services

Contact CDD

612-626-3545

prabh025@umn.edu

Our capabilities include pharmaceutical formulation development for NDA and ANDA dosage forms, excipient compatibility studies, process development of existing dosage forms, optimization of existing drug formulations, qualitative / quantitative evaluation of proprietary dosage forms and troubleshooting. 

Solids

  • Tablets (Immediate release, Modified release, Sustained release, Chewable Lozenges)
  • Capsules (hard gelatin, granulated or dilution blend, liquid filled)
  • Direct compression, Dry and Wet granulation, Bead coating, and Lyophilization

Liquids and Semi-Solids 

(oral, mucosal, topical, parenteral)

  • Emulsions and micro-emulsions
  • Gels (aqueous, non-aqueous)
  • Suspensions
  • Oral Liquids
  • Development of dosage forms and preservative systems
  • Lyophilization

Injectable and Ophthalmics

  • Preservative-free Ophthalmics
  • Ophthalmic Solutions and Suspensions
  • Lyophilized powders for injection
  • Injectable solutions

Novel technologies

  • Hydrogels
  • Nano and Micro particles
    • Polymeric nanoparticles
    • Self-emulsifying micro emulsions and dispersions
    • Solid lipid nanoparticles
  • Polymer scaffolds
  • Extended Topicals
    • Transdermal drug delivery
    • Controlled release Topicals